Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2000
11/02/2000WO2000064894A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000WO2000064878A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
11/02/2000WO2000064874A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000WO2000064866A1 Diphenylurea derivatives
11/02/2000WO2000064520A1 Powder inhaler for combined medicament
11/02/2000WO2000064486A2 Enzymatically activated polymeric drug conjugates
11/02/2000WO2000064485A2 Specifically targeted catalytic antagonists and uses thereof
11/02/2000WO2000064479A1 Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders
11/02/2000WO2000064478A1 Preventives/remedies for liver diseases
11/02/2000WO2000064474A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
11/02/2000WO2000064436A1 Methods of delivery of cetyl myristoleate
11/02/2000WO2000064433A1 Ketoprofen microgranules, preparation method and pharmaceutical compositions
11/02/2000WO2000064432A1 Ketoprofen microgranules, method for preparing same and pharmaceutical compositions
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000039136A3 Human brainiac-5
11/02/2000WO2000037504A9 Human monoclonal antibodies to ctla-4
11/02/2000WO2000033878A3 Stabilization of macrolides
11/02/2000EP1048657A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
11/02/2000EP1048649A1 5-arylpyrrole derivatives
11/02/2000EP1048299A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/02/2000EP1047782A1 Interleukin-1 receptor antagonist beta (il-1ra beta)
11/02/2000EP1047772A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047769A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd
11/02/2000EP1047713A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047698A1 Piperazino derivatives as neurokinin antagonists
11/02/2000EP1047694A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
11/02/2000EP1047688A1 Thiophene nitrone compounds
11/02/2000EP1047683A1 Thioether furan nitrone compounds
11/02/2000EP1047678A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP1047673A1 Novel heterocyclic compounds
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use
11/02/2000EP1047425A1 Integrin receptor antagonists
11/02/2000EP1047424A1 Il-8 receptor antagonists
11/02/2000EP0888316B1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors
11/02/2000EP0790059A4 Means for treating auto-immune diseases and method of treatment
11/02/2000EP0662148B1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
11/02/2000CA2371662A1 Peptide homodimers and peptide heterodimers, derived from interferon .alpha.2
11/02/2000CA2371064A1 Methods of delivery of cetyl myristoleate
11/02/2000CA2370264A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000CA2369999A1 Enzymatically activated polymeric drug conjugates
11/02/2000CA2369092A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000CA2368213A1 Specifically targeted catalytic antagonists and uses thereof
11/02/2000CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same
11/01/2000CN1271606A Efficient medicinal core (capsule) for relieving rheumatic pain or common cold and antalgic purpose
11/01/2000CN1058021C New peptides derived from trifluorumethylketones, process for their preparation and pharmaceutical compositions which contain them
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
11/01/2000CN1057937C Use of lysozyme dimer and preparations containing same
11/01/2000CN1057932C Traditional Chinese medicine composition for external use of curing rheumatic arthritis
11/01/2000CN1057924C Drug preparation for curing viral and many kinds of myocarditis, low fever and hypokalemia
10/2000
10/31/2000US6140363 Administering rosmarinic acid, its derivative or prunella vulgaris extract for suppressing immune response for treatment, prevention, or diagnosis of rejection of transplanted organ or tissue, chronic rejection
10/31/2000US6140344 For treating pathological conditions such as asthma, rhinitis, eczema and parasitic infections featuring tissue eosinophilia
10/31/2000US6140335 Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase
10/31/2000US6140327 Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
10/31/2000US6140312 Nontoxic, for treating skin diseases
10/31/2000US6140308 Colon or ileum-specific glucocorticosteroid derivatives
10/31/2000US6140124 Nucleotide sequences which target untranslated regions, translation start site and translation termination position; for diagnosis and treatment of tumors, inflammation and arthritis; antitumor agents; inflammatory agents
10/31/2000US6139866 Tape formulation for percutaneous administration containing fentanyi
10/31/2000US6139856 Composition useful for providing one-step surgical preparation and drape
10/31/2000CA2182004C Film coated tablet of paracetamol and domperidone
10/31/2000CA2152621C Pharmaceutical compositions comprising contignasterol compounds
10/31/2000CA2151724C Antipyretic and analgesic methods and compositions containing optically pure r-ketorolac
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063415A1 Dna encoding the human vanilloid receptor vr1
10/26/2000WO2000063379A2 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000WO2000063376A1 Adipocyte complement related protein homolog zacrp2
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063371A1 Protease activated receptor 2 variants
10/26/2000WO2000063351A2 Carbohydrate-modifying enzymes
10/26/2000WO2000063251A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063234A2 Pyrrolidincarbonylamino cyclic disulfides as vcam-vla4 antagonists
10/26/2000WO2000063228A1 Ent-steroids as selectively active estrogens
10/26/2000WO2000063221A2 Galectin 11
10/26/2000WO2000063210A1 Morphinoid compounds
10/26/2000WO2000063208A1 Substituted imidazoles, their preparation and use
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063197A1 Hydroxamic acid derivative
10/26/2000WO2000063194A1 Sulfonamide derivatives having oxadiazole rings
10/26/2000WO2000063191A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
10/26/2000WO2000063181A1 Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins
10/26/2000WO2000063178A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
10/26/2000WO2000063165A1 Mmp inhibitor
10/26/2000WO2000063159A1 (-)-verbenone derivatives
10/26/2000WO2000063148A1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions
10/26/2000WO2000062806A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/26/2000WO2000062795A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/26/2000WO2000062791A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000WO2000062789A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000062770A1 Compounds useful as phosphotyrosine mimics
10/26/2000WO2000062767A2 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000062744A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000062740A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/26/2000WO2000039120A3 Compounds and methods for modulation of estrogen receptors
1 ... 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 ... 1272